Tuesday, October 7, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

NetApp Inc Exceeds Expectations with Strong ThirdQuarter Results and Positive Analyst Outlook

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Fiances and technology
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

NetApp, Inc. (NASDAQ: NTAP) exceeded market expectations with its strong third-quarter financial results, reporting adjusted earnings per share of $1.94 and quarterly sales of $1.61 billion. Looking ahead to the fourth quarter, NetApp anticipates adjusted earnings between $1.73 to $1.83 per share and net revenues ranging from $1.585 billion to $1.735 billion.

Barclays, Evercore ISI Group, and TD Cowen all raised NetApp’s price targets, reflecting confidence in the company’s growth prospects. The average 12-month price target for NetApp is $89.93, with a high forecast of $105.00 and a low forecast of $73.00. Analyst consensus rates NetApp as a Hold based on ratings from 16 Wall Street analysts.

Following NetApp’s positive financial performance, analysts have adjusted their price targets upwards, reaffirming confidence in the company’s market position and future growth potential.

NTAP Stock Shows Strong Performance on March 1, 2024: Potential for Further Growth

On March 1, 2024, NTAP stock showed strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been experiencing positive price momentum and may continue to see upward movement in the near future.

The price of NTAP shares increased by $1.09 since the market last closed, representing a 1.24% rise from the previous closing price of $89.12. Additionally, in pre-market trading, the stock rose by $16.78, further demonstrating the bullish sentiment surrounding NTAP on that day.

Investors may be drawn to NTAP due to its strong price performance and potential for further growth. Trading near the top of its 52-week range suggests that the stock has been performing well compared to its historical prices, which could attract more buyers looking to capitalize on the positive momentum.

Overall, NTAP’s strong performance on March 1, 2024, indicates that the stock may be worth considering for investors looking for opportunities in the market. However, as with any investment, it is crucial to carefully assess the risks and potential rewards before making a decision.

NetApp Inc. (NTAP) Stock Shows Strong Performance with Impressive Financial Results

On March 1, 2024, NetApp Inc. (NTAP) stock showed strong performance based on its recent financial results. According to data from CNN Money, the company reported total revenue of $6.36 billion for the past year, which remained flat compared to the previous year. However, there was an 8.94% increase in total revenue since the last quarter, reaching $1.56 billion.

Net income for NetApp Inc. was reported at $1.27 billion for the past year, showing a significant increase of 35.97% compared to the previous year. The net income also increased by 56.38% since the last quarter, reaching $233.00 million.

Earnings per share (EPS) for NetApp Inc. stood at $5.79 for the past year, reflecting a 41.53% increase from the previous year. The EPS also increased by 60.09% since the last quarter, reaching $1.10.

Overall, these financial results indicate a strong performance for NetApp Inc. on March 1, 2024. Investors and analysts may view these results as a signal of strong financial health and growth potential for NetApp Inc. Moving forward, it will be important to monitor the company’s performance to see if it can sustain this positive momentum in the coming quarters.

Tags: NTAP
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Bull Market

Analyst Maintains Positive Outlook on Endava with Adjusted Price Target

Ai Sleeping

Sleep Quality's Impact on Physical and Financial Well-Being

DVY stock news

Truist Securities Analyst Reiterates Hold Recommendation on Best Buy Co

Recommended

Xoma Stock

The Royalty Aggregator: Xoma’s Unique Path to Biotech Profits

1 month ago

Revolutionizing Mental Health Care Neuronetics and Transformations Care Network Forge GameChanging Partnership

2 years ago
Investings on laptop and finances

Title Payoneer Global Remains Optimistic Despite Revenue Projection Dip

2 years ago
Graftech Stock

GrafTech Implements Reverse Stock Split Amid Executive Departure

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

C3.ai Stock: Navigating a Crossroads of Promise and Peril

MediaAlpha Shares: A Battle Between Conflicting Signals

M&T Bank Shares: Can Strong Fundamentals Overcome Market Weakness?

Opendoor Shares Surge on Cryptocurrency Payment Initiative

ASML Shares Surge as JP Morgan Lifts Price Target Ahead of Earnings

Energy Vault Shares Maintain Impressive Growth Trajectory

Trending

Arvinas Stock
Analysis

Biotech Firm Arvinas Surges on Promising Parkinson’s Treatment Data

by Andreas Sommer
October 7, 2025
0

Shares of Arvinas are experiencing a significant rally following the release of encouraging clinical trial results for...

Harmony Biosciences Holdings Stock

Clinical Trial Failure Sends Harmony Biosciences Shares Plunging

October 7, 2025
Bellring Brands LLC Stock

Bellring Brands Shares: Is the Downturn Sustainable?

October 7, 2025
C3.ai Stock

C3.ai Stock: Navigating a Crossroads of Promise and Peril

October 7, 2025
Mediaalpha Stock

MediaAlpha Shares: A Battle Between Conflicting Signals

October 7, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Biotech Firm Arvinas Surges on Promising Parkinson’s Treatment Data
  • Clinical Trial Failure Sends Harmony Biosciences Shares Plunging
  • Bellring Brands Shares: Is the Downturn Sustainable?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com